Meta Platforms, Inc. (NASDAQ: META) as plotted in Plotly. Data sourced from Yahoo Finance, using R.

This is the cost of equity capital (Re), determined using the Capital Asset Pricing Model, and time series data for the risk-free rate (Rf), beta, and the market rate of return (Rm), where Rm was calculated using Damodaran's method, automated in R on a time series basis.

This is the cost of equity capital (Re), determined using the Capital Asset Pricing Model, and time series data for the risk-free rate (Rf), beta, and the market rate of return (Rm), where Rm was calculated using Damodaran's method, automated in R on a time series basis.

This is the cost of equity capital (Re), determined using the Capital Asset Pricing Model, and time series data for the risk-free rate (Rf), beta, and the market rate of return (Rm), where Rm was calculated using Damodaran's method, automated in R on a time series basis.

This is the 1-year, daily beta of Meta Platforms, Inc. (NASDAQ: META), with respect to the S&P 500.

This is the 2-year, weekly beta of Meta Platforms, Inc. (NASDAQ: META), with respect to the S&P 500.

This is the 5-year, monthly beta of Meta Platforms, Inc. (NASDAQ: META), with respect to the S&P 500.

This is the 1-year, daily beta of Meta Platforms, Inc. (NASDAQ: META), with respect to the VIX.

This is the 2-year, weekly beta of Meta Platforms, Inc. (NASDAQ: META), with respect to the VIX.

This is the 5-year, monthly beta of Meta Platforms, Inc. (NASDAQ: META), with respect to the VIX.

Equity risk premium, as plotted in Plotly. Earnings forecasts sourced from Damodaran's work on the ERP.

This is a plot of the S&P 500 (SPX) from 1/10/2007 to 12/01/2022.

This plot is a decimal representation of the 10-Year Treasury yield, from 1/10/2007 to 12/01/2022.

Time series forecast of the segment revenues, of Merck & Co., Inc. (NYSE: MRK). Forecast as the average of additive and multiplicative time series forecasts, using data from 1Q15 to 3Q21. Forecasts run from 4Q21 to 4Q23.

Cumulative Returns on GILD, AZN, and ABBV, vs. SPX

Gilead Sciences, Inc. (NASDAQ: GILD), as plotted in Plotly. Data sourced from Yahoo Finance, using R.

AstraZeneca PLC (NYSE: AZN), as plotted in Plotly. Data sourced from Yahoo Finance, using R.

Cumulative returns on Gilead Sciences, Inc. (NASDAQ: GILD) and AstraZeneca PLC (NYSE: AZN), plotted against the S&P 500. Data sourced from Yahoo Finance, using R.

This time series describes the 1-year, daily, beta of AZN with respect to the S&P 500 index (^GSPC in Yahoo Finance), over a 5-year interval. Data were sourced from Yahoo Finance, using R.

This time series describes the 1-year, daily, beta of GILD with respect to the S&P 500 index (^GSPC in Yahoo Finance), over a 5-year interval. Data were sourced from Yahoo Finance, using R.

Surface plot of the time series of the US yield curve. Data sourced from Investing.com, using Selenium in Python. Plotted with Plotly in R.

Surface plot of the time series of the US yield curve. Data sourced from Investing.com, using Selenium in Python. Plotted with Plotly in R.

Surface plot of the time series of the US yield curve. Data sourced from Investing.com, using Selenium in Python. Plotted with Plotly in R.

This time series describes the 1-year, daily, beta of the S&P 500 index (^GSPC in Yahoo Finance) with respect to the CBOE VIX (^VIX). Data were sourced from Yahoo Finance, using R.

This time series describes the 1-year, daily, beta of the NASDAQ Composite Index (^IXIC) with respect to the CBOE VIX (^VIX). Data were sourced from Yahoo Finance, using R.

This time series describes the 1-year, daily, beta of the Russell 2000 index (^RUT) with respect to the CBOE VIX (^VIX). Data were sourced from Yahoo Finance, using R.

This time series describes the 1-year, daily, beta of the Dow Jones Industrial Average (^DJI in Yahoo Finance) with respect to the CBOE VIX (^VIX). Data were sourced from Yahoo Finance, using R.

Cumulative returns on Bristol-Myers Squibb and Celgene vs. the performance of US indices (SPX, DJIA, IXIC, RUT).

This time series describes the 2-year, weekly, beta of Bristol-Myers Squibb Company (NYSE: BMY) with respect to the S&P 500 (^SPX). Data were sourced from Yahoo Finance, using R.

This time series describes the 2-year, weekly, beta of Celgene Corporation (NASDAQ: CELG) with respect to the S&P 500 (^SPX). Data were sourced from Yahoo Finance, using R.

Bristol-Myers Squibb Company (NYSE: BMY), as plotted in Plotly. Data sourced from Investing.com, using selenium in Python.

Time series forecast of the segment revenues, of Bristol-Myers Squibb Company (NYSE: BMY). Forecast by the additive model of time series forecasting, using data from 1Q2013 to 3Q2019.

Time series forecast of the segment revenues, of Bristol-Myers Squibb Company (NYSE: BMY). Forecast by the additive model of time series forecasting, using data from 1Q2013 to 3Q2019.

Celgene Corporation (NASDAQ: CELG), as plotted in Plotly. Data sourced from Investing.com, using selenium in Python.

Time series forecast of the segment revenues, of Celgene Corporation (NASDAQ: CELG). Forecast by the additive model of time series forecasting, using data from 1Q2013 to 3Q2019.

Time series forecast of the segment revenues, of Celgene Corporation (NASDAQ: CELG). Forecast by the additive model of time series forecasting, using data from 1Q2013 to 3Q2019.

LVMH MOËT HENNESSY LOUIS VUITTON SA (XPAR: MC), as plotted in Plotly. Data sourced from Investing.com, using selenium in Python.

Time series forecast of the segment revenues, of LVMH Moët Hennessy Louis Vuitton SE (XPAR: MC). Forecast as the average of additive and multiplicative time series forecasts, using data from 1Q2013 to 3Q2019.

Time series forecast of the segment revenues, of LVMH Moët Hennessy Louis Vuitton SE (XPAR: MC). Forecast as the average of additive and multiplicative time series forecasts, using data from 1Q2013 to 3Q2019.

Tiffany & Co. (NYSE: TIF), as plotted in Plotly. Data sourced from Investing.com, using selenium in Python.

Time series forecast of the segment revenues, of Tiffany & Co. (NYSE: TIF). Forecast as the maximum of additive and multiplicative time series forecasts, using data from 1Q2013 to 3Q2019.

Time series forecast of the segment revenues, of Tiffany & Co. (NYSE: TIF). Forecast as the maximum of additive and multiplicative time series forecasts, using data from 1Q2013 to 3Q2019.

Time series forecast of the segment revenue, and total revenues, of Edwards Lifesciences Corporation (NYSE: EW). Multiplicative time series forecast, using data from 1Q2013 to 2Q2019.

Business valuation of Eastman Chemical Company (NYSE: EMN). Historical data used to test system for football field chart summaries.

Year to Date Correlation Matrix on US Bond Yields (YTM)

Year to Date Time Series of US bond yields.

Year to date surface plot of the time series of the US yield curve.

Year to date surface plot of the time series of the Chinese yield curve.

Year to Date Time Series of Chinese bond yields.

Year to Date Correlation Matrix on Chinese Bond Yields (YTM)

Cumulative returns on the S&P 500 and VIX since 01/03/2007, displaying the characteristic inverse relationship between the two.

Cumulative returns on selected industry ETFs vs. the performance of the S&P 500 (SPX).

Percent changes in bond yields.

Recent cumulative returns on selected commodity/real asset ETFs.

Recent cumulative returns on selected sector ETFs.